Pay in 4 interest-free payments of $5.66 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
Further research must be conducted on the additional potential benefits of DPP-4 inhibitors before the recommendation for DPP-4 inhibitors over SGLT2 inhibitors or GLP-1 agonists as a second-line agent for patients with type 2 diabetes can be strengthened
Quelle: Xie et al., Frontiers Pharmacol 2025 Die andere Seite: Was GLP-1-Medikamente nachweislich leisten Wer nur auf die Nebenwirkungen schaut, bersieht die andere Seite der Medaille
Similar findings have been observed in healthy adults, where doses of 5 to 10 grams reduced post-meal glucose area under the curve (AUC)
GLP-1 receptor agonists mimic the action of a natural hormone called glucagon-like peptide-1 (GLP-1), which is released in response to eating
US$ 27.55
US$ 24.41
US$ 28.70
US$ 29.62
